Jelena Jovanović

Assessment of Minimal Residual Disease in Standard-Risk AML

Adam Ivey, Robert K. Hills, Michael A. Simpson et al. · New England Journal of Medicine · 2016 · 836 citations · Full text

Medicine, Hematology, Molecular Genetics +16

Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized <i>WT1</i> Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study

Daniela Cilloni, Aline Renneville, Fabienne Hermitte et al. · Journal of Clinical Oncology · 2009 · 434 citations · Full text

Medicine, Hematology, Oncology +17

Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide Therapy

David Grimwade, Jelena Jovanović, Robert K. Hills et al. · Journal of Clinical Oncology · 2009 · 356 citations · Full text

Medicine, Hematology, Oncology +17

Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA–positive chronic eosinophilic leukemia

Jelena Jovanović, Joannah Score, Katherine Waghorn et al. · Blood · 2007 · 204 citations · Full text

Medicine, Pharmacotherapy, Immunopathology +3

Molecular MRD status and outcome after transplantation in NPM1-mutated AML

Richard Dillon, Robert K. Hills, Sylvie Freeman et al. · Blood · 2020 · 166 citations · Full text

Medicine, Molecular Biology, Oncology +3